世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Frontotemporal Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4238
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、前頭側頭型認知症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（向知性薬、抗精神病薬、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・前頭側頭型認知症治療の市場動向
・企業の競争状況、市場シェア
・前頭側頭型認知症治療の種類別市場規模と予測2016-2027（向知性薬、抗精神病薬、抗うつ薬、中枢神経刺激薬、その他）
・前頭側頭型認知症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・前頭側頭型認知症治療の北米市場規模2016-2027（アメリカ、カナダ）
・前頭側頭型認知症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・前頭側頭型認知症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・前頭側頭型認知症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・前頭側頭型認知症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Pfizer、Sanofi、Eli Lilly、Merck、Johnson & Johnson、AstraZeneca、Allergan、Mylan）
・結論

Market Analysis and Insights: Global Frontotemporal Disorders Treatment Market
The global Frontotemporal Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Frontotemporal Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Frontotemporal Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Frontotemporal Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Frontotemporal Disorders Treatment market.

Global Frontotemporal Disorders Treatment Scope and Market Size
Frontotemporal Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Frontotemporal Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cognitive Enhancers
Antipsychotics
Antidepressants
CNS Stimulants
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Pfizer
Sanofi
Eli Lilly
Merck
Johnson & Johnson
AstraZeneca
Allergan
Mylan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Frontotemporal Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cognitive Enhancers
1.2.3 Antipsychotics
1.2.4 Antidepressants
1.2.5 CNS Stimulants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Frontotemporal Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Frontotemporal Disorders Treatment Market Perspective (2016-2027)
2.2 Frontotemporal Disorders Treatment Growth Trends by Regions
2.2.1 Frontotemporal Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Frontotemporal Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Frontotemporal Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Frontotemporal Disorders Treatment Industry Dynamic
2.3.1 Frontotemporal Disorders Treatment Market Trends
2.3.2 Frontotemporal Disorders Treatment Market Drivers
2.3.3 Frontotemporal Disorders Treatment Market Challenges
2.3.4 Frontotemporal Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Frontotemporal Disorders Treatment Players by Revenue
3.1.1 Global Top Frontotemporal Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Frontotemporal Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Frontotemporal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Frontotemporal Disorders Treatment Revenue
3.4 Global Frontotemporal Disorders Treatment Market Concentration Ratio
3.4.1 Global Frontotemporal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Frontotemporal Disorders Treatment Revenue in 2020
3.5 Frontotemporal Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Frontotemporal Disorders Treatment Product Solution and Service
3.7 Date of Enter into Frontotemporal Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Frontotemporal Disorders Treatment Breakdown Data by Type
4.1 Global Frontotemporal Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Frontotemporal Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Frontotemporal Disorders Treatment Breakdown Data by Application
5.1 Global Frontotemporal Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Frontotemporal Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Frontotemporal Disorders Treatment Market Size (2016-2027)
6.2 North America Frontotemporal Disorders Treatment Market Size by Type
6.2.1 North America Frontotemporal Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Frontotemporal Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Frontotemporal Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Frontotemporal Disorders Treatment Market Size by Application
6.3.1 North America Frontotemporal Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Frontotemporal Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Frontotemporal Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Frontotemporal Disorders Treatment Market Size by Country
6.4.1 North America Frontotemporal Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Frontotemporal Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Frontotemporal Disorders Treatment Market Size (2016-2027)
7.2 Europe Frontotemporal Disorders Treatment Market Size by Type
7.2.1 Europe Frontotemporal Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Frontotemporal Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Frontotemporal Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Frontotemporal Disorders Treatment Market Size by Application
7.3.1 Europe Frontotemporal Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Frontotemporal Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Frontotemporal Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Frontotemporal Disorders Treatment Market Size by Country
7.4.1 Europe Frontotemporal Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Frontotemporal Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Frontotemporal Disorders Treatment Market Size (2016-2027)
9.2 Latin America Frontotemporal Disorders Treatment Market Size by Type
9.2.1 Latin America Frontotemporal Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Frontotemporal Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Frontotemporal Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Frontotemporal Disorders Treatment Market Size by Application
9.3.1 Latin America Frontotemporal Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Frontotemporal Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Frontotemporal Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Frontotemporal Disorders Treatment Market Size by Country
9.4.1 Latin America Frontotemporal Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Frontotemporal Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Frontotemporal Disorders Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Frontotemporal Disorders Treatment Introduction
11.2.4 Pfizer Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Frontotemporal Disorders Treatment Introduction
11.3.4 Sanofi Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Frontotemporal Disorders Treatment Introduction
11.4.4 Eli Lilly Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Frontotemporal Disorders Treatment Introduction
11.5.4 Merck Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Frontotemporal Disorders Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Frontotemporal Disorders Treatment Introduction
11.7.4 AstraZeneca Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Frontotemporal Disorders Treatment Introduction
11.8.4 Allergan Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.8.5 Allergan Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Frontotemporal Disorders Treatment Introduction
11.9.4 Mylan Revenue in Frontotemporal Disorders Treatment Business (2016-2021)
11.9.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Frontotemporal Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cognitive Enhancers
Table 3. Key Players of Antipsychotics
Table 4. Key Players of Antidepressants
Table 5. Key Players of CNS Stimulants
Table 6. Key Players of Others
Table 7. Global Frontotemporal Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Frontotemporal Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Frontotemporal Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Frontotemporal Disorders Treatment Market Share by Regions (2016-2021)
Table 11. Global Frontotemporal Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Frontotemporal Disorders Treatment Market Share by Regions (2022-2027)
Table 13. Frontotemporal Disorders Treatment Market Trends
Table 14. Frontotemporal Disorders Treatment Market Drivers
Table 15. Frontotemporal Disorders Treatment Market Challenges
Table 16. Frontotemporal Disorders Treatment Market Restraints
Table 17. Global Frontotemporal Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Frontotemporal Disorders Treatment Market Share by Players (2016-2021)
Table 19. Global Top Frontotemporal Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Frontotemporal Disorders Treatment as of 2020)
Table 20. Ranking of Global Top Frontotemporal Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Frontotemporal Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Frontotemporal Disorders Treatment Product Solution and Service
Table 24. Date of Enter into Frontotemporal Disorders Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Frontotemporal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Frontotemporal Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Frontotemporal Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Frontotemporal Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Frontotemporal Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Frontotemporal Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Frontotemporal Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Frontotemporal Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Frontotemporal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Frontotemporal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Frontotemporal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Frontotemporal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Frontotemporal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Frontotemporal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Frontotemporal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Frontotemporal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Frontotemporal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Frontotemporal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Frontotemporal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Frontotemporal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Frontotemporal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Frontotemporal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Frontotemporal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Frontotemporal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Frontotemporal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Frontotemporal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Frontotemporal Disorders Treatment Product
Table 67. GlaxoSmithKline Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Frontotemporal Disorders Treatment Product
Table 72. Pfizer Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Frontotemporal Disorders Treatment Product
Table 77. Sanofi Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Frontotemporal Disorders Treatment Product
Table 82. Eli Lilly Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Frontotemporal Disorders Treatment Product
Table 87. Merck Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Frontotemporal Disorders Treatment Product
Table 92. Johnson & Johnson Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Frontotemporal Disorders Treatment Product
Table 97. AstraZeneca Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. Allergan Company Details
Table 100. Allergan Business Overview
Table 101. Allergan Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 102. Allergan Recent Development
Table 103. Mylan Company Details
Table 104. Mylan Business Overview
Table 105. Mylan Frontotemporal Disorders Treatment Product
Table 106. Mylan Revenue in Frontotemporal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 107. Mylan Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Frontotemporal Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cognitive Enhancers Features
Figure 3. Antipsychotics Features
Figure 4. Antidepressants Features
Figure 5. CNS Stimulants Features
Figure 6. Others Features
Figure 7. Global Frontotemporal Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Frontotemporal Disorders Treatment Report Years Considered
Figure 12. Global Frontotemporal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Frontotemporal Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Frontotemporal Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Frontotemporal Disorders Treatment Market Share by Regions (2022-2027)
Figure 16. Global Frontotemporal Disorders Treatment Market Share by Players in 2020
Figure 17. Global Top Frontotemporal Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Frontotemporal Disorders Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Frontotemporal Disorders Treatment Revenue in 2020
Figure 19. Global Frontotemporal Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Frontotemporal Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Frontotemporal Disorders Treatment Market Share by Type (2016-2027)
Figure 23. North America Frontotemporal Disorders Treatment Market Share by Application (2016-2027)
Figure 24. North America Frontotemporal Disorders Treatment Market Share by Country (2016-2027)
Figure 25. United States Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Frontotemporal Disorders Treatment Market Share by Type (2016-2027)
Figure 29. Europe Frontotemporal Disorders Treatment Market Share by Application (2016-2027)
Figure 30. Europe Frontotemporal Disorders Treatment Market Share by Country (2016-2027)
Figure 31. Germany Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Frontotemporal Disorders Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Frontotemporal Disorders Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Frontotemporal Disorders Treatment Market Share by Region (2016-2027)
Figure 41. China Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Frontotemporal Disorders Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Frontotemporal Disorders Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Frontotemporal Disorders Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Frontotemporal Disorders Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Frontotemporal Disorders Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Frontotemporal Disorders Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Frontotemporal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 67. Allergan Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界のミトコンドリア病治療市場規模・現状・予測（2021年-2027年）

Global Mitochondrial Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5865 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ミトコンドリア病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダイエット療法、ビタミン・サプリメント療法、パイプライン療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の上肢障害治療市場規模・現状・予測（2021年-2027年）

Global Upper Extremities Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4999 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、上肢障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（置換＆骨折、神経疾患、軟部組織損傷）、用途別市場規模（病院・外科センター、整形外科センター、外科医院）、主要地域別市場規模（北米、アメリカ、...

世界の神経疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4568 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経系（CNS）、末梢神経系（PNS））、用途別市場規模（麻痺、筋力低下、協調運動不全、感覚喪失、発作、錯乱、疼痛、意識レベル変化）、...

世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年）

Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5740 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、女性性機能障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-4248 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（...

世界のバイオパンクチャー治療市場規模・現状・予測（2021年-2027年）

Global Biopuncture Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5621 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、バイオパンクチャー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルニカ、エキナセア、カモミール、その他）、用途別市場規模（婦人科系疾患、精神科系疾患、筋骨格系疾患、整形外科系疾患、消化器系疾患...

世界のリウマチ疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Rheumatic Disorders Drug Market Size, Status and Forecast 2021-2027
QFJ1-5995 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、リウマチ疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍壊死因子-α作用型、インターロイキン・インターロイキン受容体作用型、プロテインキナーゼ作用型、細胞表面抗原作用型、ホルモン・ホルモ...

世界の糖原病（GSD）臨床試験市場規模・現状・予測（2021年-2027年）

Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, Status and Forecast 2021-2027
QFJ1-4266 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、糖原病（GSD）臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の神経代謝障害市場規模・現状・予測（2021年-2027年）

Global Neurometabolic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-5881 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、神経代謝障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゴーシェ病、ファブリー病、ポンペ病、ムコ多糖症VI型、その他）、用途別市場規模（経口、非経口）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年） The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream. Market Analysis and Insights: Global Urea Cycle Disorders (UCD) Treatment Market The global Urea Cycle Disorders (UCD) Tre…
世界のミトコンドリア病治療市場規模・現状・予測（2021年-2027年） Mitochondrial disorders are inherited chronic disorders characterized by a wide range of biochemical and genetic mitochondrial defects and mutations. The disorder affects multiple organs, which includes brain, heart, liver, skeletal muscles, kidney, and respiratory systems. Market Analysis and Insig…
世界の上肢障害治療市場規模・現状・予測（2021年-2027年） The upper extremities are multi-layered sheath-like parts formed by bones, muscles, vascular nerves, and superficial, deep fascia and skin. Can be divided into shallow and deep two-layer structure. Symptoms of upper extremity disease may include reduced ability to use the affected parts of the limb,…
世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…
世界の副甲状腺機能低下症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypoparathyroidism Treatment Market The global Hypoparathyroidism Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…